Pharmaceutical Impurities Webinars
Dec 11, 2018
- Jan 17, 2019
Join our pharmaceutical impurities webinars to hear from leaders in the field how you can optimize your impurity analysis workflows to obtain greater productivity, sensitivity, accuracy and reproducibility to meet increasing regulatory requirements and lower limits of detection. Learn how to achieve all of this, whilst also increasing laboratory efficiency and reducing the cost per sample.
Please sign-up below to receive the access details to the webinar sessions of choice. Audio will be available by phone only.
For questions about these webinars or regarding your registration please contact us at firstname.lastname@example.org.
Dec 11, 2018 - Dec 11, 2018
At this first session Dr. Christian Zeine will present an overview of the topic of pharmaceutical impurities including what constitutes an impurity, the various types of impurities, the regulatory guidelines and detection limits and the important points to consider during impurity testing. In addition, briefly introducing why to use reference standards and the main points to consider during their use.
Speaker: Dr. Christian Zeine, LGC Standards
Dec 13, 2018 - Dec 13, 2018
During this webinar novel and existing inorganic impurities will be discussed and how ICP-MS can being utilized and optimized to obtain ultimate sensitivity and rapid detection and quantitiation of such impurities. Also how automatic method development can improve productivity.
Speakers: Kirsty Mcintyre, LGC Standards and Simon Nelms, Thermo Fisher Scientific
Jan 15, 2019 - Jan 15, 2019
Strategies will be shown to improve productivity, reduce cost per sample and gain deeper insights for organic impurity analysis using novel UHPLC and detector technology. How to achieve confirmation, identification and quantification simultaneously with a multi-detector approach. What are the benefits to using IC-MS comapred to standard IC with conductivity?
Speaker: Dr. Heiko Herrmann, Thermo Fisher Scientific
Jan 17, 2019 - Jan 17, 2019
In this webinar, Broughton Laboratories will discuss their work in the area of pharmaceutical impurities focusing on method development and validation of related substances, stability studies and impurity profiling and the investigation of unknown impurities.
Speaker: Elaine Corcoran, Broughton Laboratories
Prior to the workshop, why not take a look at these articles related to pharmaceutical impurities: